Atlas Trials

Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated With Basal Insulin in Finland

Clinical trial NCT06268821 · TERMINATED

Trial details

NCT number
NCT06268821
Sponsor
Abbott Diabetes Care
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 2 Diabetes Treated With Insulin
Start date
2024-04-02
Primary completion
2024-07-12
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.